Invention to Innovation: Demystifying commercialization

Invention to Innovation is the SickKids-exclusive commercialization education series, hosted by the Industry Partnerships & Commercialization office. Throughout this series, attendees can expect to learn more about the commercialization path and what it takes to bring inventions from the lab to patients, see presentations from industry experts, and hear success stories from entrepreneurs in our own ecosystem.

All events are recorded and are available on the IP&C internal website.

These events are for SickKids employees only. To learn more about our education series, contact Gaurie Aggarwal, Project Manager.


Session 1  |  Taking SickKids Innovations from Lab Bench to Bedside

In this first session, Konrad Powell-Jones, the Director of Business Development at IP&C, will walk you through the commercialization process and its benefits, discuss SickKids’ policies, give examples of successful commercialization, highlight opportunities, and provide a deep dive on how IP&C works closely with researchers and inventors to bring their technologies to patients through the partnership and commercialization process.

Meet our speaker:

Konrad Powell-Jones | Director, Business Development

In his role as Director of Business Development, Konrad applies his extensive pharma and tech transfer experience in leading the SickKids IP&C business development team. With over 25 years of combined experience as a Biotechnology Commercialization Manager for institutions such as the University of Toronto, The Canadian Arthritis Network, Centre for Addiction and Mental Health (CAMH) and Sinai Health System, and over 15 years as a Contracts Specialist for CAMH and other hospitals affiliated with the University of Toronto, he brings a broad spectrum of knowledge to commercializing early-stage discoveries out of our institution.

Session 2  |  Beyond Research: Developing Biopharma Technologies


Meet our speakers:

Mounia Azzi, PhD | VP, Program Development & Partnerships

As Vice President, Program Development and Partnerships, Dr. Azzi is leading adMare’s project identification and scientific and commercial evaluation process, ensuring a robust and strategically diverse pipeline for the organization.

With deep experience in corporate and business development, Dr. Azzi is working closely with adMare’s Venture Partners to build their portfolios through new program creation, asset identification and investment area development. In doing so, she is playing a key role in advancing adMare’s Mission to source therapeutically and commercially promising research from leading academic and biotech partners from across Canada to create and grow companies of scale.

Dr. Azzi holds a PhD in Neuroscience from Université Pierre et Marie Curie (UPMC) in Paris.

Amie Phinney, PhD, MBA | Sr. Director, Program Development & Partnerships

As the Sr. Director for the Program Development and Partnership team at adMare BioInnovations, Amie Phinney uses her biomedical research and business background to create and guide scientific collaborations.

Most recently, Amie was at Northwestern University in Chicago, where she led an academic-VC partnership aimed at translating academic discoveries into novel therapeutics. Prior to Northwestern University, she gained extensive experience managing academic-pharma collaborations and biotech-pharma alliances at Abbott and AbbVie Labs in Chicago.

Amie received her BSc at University of Guelph, her PhD in Biomedical Research at the University of Basel in Switzerland, and her MBA at Lake Forest Graduate School of Management in Chicago.

Session 3  |  Advancing R&D in Collaboration with Industry


Session 4  |  So you want to start a company? Key considerations for you biotech start-up